Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 1
2009 2
2010 1
2012 1
2013 4
2014 5
2016 2
2017 3
2018 4
2019 10
2020 7
2021 4
2022 2
2023 4
2024 4
2025 3
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.
Nicholls SJ, Pavo I, Bhatt DL, Buse JB, Del Prato S, Kahn SE, Lincoff AM, McGuire DK, Miller D, Nauck MA, Nishiyama H, Nissen SE, Sattar N, Weerakkody G, Wiese RJ, Zinman B, Zoungas S, Basile J, Davies MJ, Giorgino F, Kellerer M, Ji L, Varkonyi T, Menon V, Broder JC, Herschtal A, D'Alessio D; SURPASS-CVOT Investigators. Nicholls SJ, et al. N Engl J Med. 2025 Dec 18;393(24):2409-2420. doi: 10.1056/NEJMoa2505928. N Engl J Med. 2025. PMID: 41406444 Clinical Trial.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Endocrinología, Diabetes y Nutrición: Year in Review 2021.
Zafon C, Caixàs A, Ballesteros M, Menéndez E, Gimeno JA, Fajardo C, Wägner AM. Zafon C, et al. Among authors: fajardo c. Endocrinol Diabetes Nutr (Engl Ed). 2021 Dec;68(10):677-679. doi: 10.1016/j.endien.2021.10.010. Epub 2021 Dec 8. Endocrinol Diabetes Nutr (Engl Ed). 2021. PMID: 34924155 No abstract available.
Predictors of therapeutic failure in GH and prolactin co-secreting pituitary adenomas.
Araujo-Castro M, Biagetti B, Menéndez E, Novoa-Testa I, Cordido F, Rodríguez Berrocal V, Pascual-Corrales E, Guerrero-Pérez F, Vicente A, García-Centeno R, González L, Ollero García MD, Irigaray Echarri A, Moure Rodríguez MD, Novo-Rodríguez C, Calatayud M, Villar-Taibo R, Bernabéu I, Alvarez-Escola C, Tenorio Jimenéz C, Abellán-Galiana P, Venegas E, González-Molero I, Iglesias P, Blanco C, Vidal-Ostos De Lara F, de Miguel Novoa MP, López-Mezquita Torres E, Hanzu F, Lamas C, Aznar Rodríguez S, Aulinas A, Recio JM, Aviles-Pérez MD, Sampedro Núñez MA, Camara R, Paja Fano M, Fajardo C, Cardoso L, Marques P, Martínez-Sáez E, Ruz-Caracuel I, Marazuela M, Puig-Domingo M. Araujo-Castro M, et al. Among authors: fajardo c. Endocr Connect. 2025 Jul 15;14(7):e250103. doi: 10.1530/EC-25-0103. Print 2025 Jul 1. Endocr Connect. 2025. PMID: 40590355 Free PMC article.
Citizen Science to Raise Antimicrobial Resistance Awareness in the Community: The MicroMundo Project in Spain and Portugal.
Gil-Serna J, Antunes P, Campoy S, Cid Á, Cobo-Molinos A, Durão P, Fajardo C, Fouz B, Freitas AR, Grosso F, de Groot PWJ, de Miguel T, Zorn BG, Hinojosa B, Leão MJ, Llagostera M, de Llanos R, Lucía A, Maicas S, Marín I, Martínez-Cañamero M, Miranda C, Molina-Guijarro JM, Moreno DA, de Los Llanos Palop M, Pérez-Álvarez MJ, Pereira PM, Pérez-Gracia MT, Quinteira S, Rioboo C, Robredo B, Rodríguez-Calleja JM, de la Haba RR, Sánchez S, Angulo MS, Sánchez-Porro C, Sangari FJ, Santos B, Silveira E, Vicedo B, Cid VJ; all members of MicroMundo Teams in Spain and Portugal. Gil-Serna J, et al. Among authors: fajardo c. Microb Biotechnol. 2025 Mar;18(3):e70123. doi: 10.1111/1751-7915.70123. Microb Biotechnol. 2025. PMID: 40035803 Free PMC article. Review.
Preference of acromegaly patients for treatment attributes in Spain.
Fajardo C, Álvarez-Escola C, Biagetti B, Garcia-Centeno R, Ciriza R, Sánchez-Cenizo L, Díaz-Muñoz M. Fajardo C, et al. Endocrine. 2023 Nov;82(2):379-389. doi: 10.1007/s12020-023-03462-z. Epub 2023 Jul 28. Endocrine. 2023. PMID: 37507554 Free PMC article.
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.
Araujo-Castro M, Biagetti B, Menéndez Torre E, Novoa-Testa I, Cordido F, Pascual-Corrales E, Rodríguez Berrocal V, Guerrero-Pérez F, Vicente A, Percovich Hualpa JC, García-Centeno R, González-Fernández L, Ollero García MD, Irigaray Echarri A, Moure Rodríguez MD, Novo-Rodríguez C, Calatayud M, Villar-Taibo R, Bernabéu I, Alvarez-Escola C, Benítez Valderrama P, Tenorio-Jiménez C, Abellán Galiana P, Venegas E, González-Molero I, Iglesias P, Blanco-Carrera C, Vidal-Ostos De Lara F, de Miguel Novoa P, López Mezquita E, Hanzu FA, Aldecoa I, Aznar S, Lamas C, Aulinas A, Asla Q, Gracia Gimeno P, Recio-Córdova JM, Avilés-Pérez MD, Asensio-Wandosell D, Sampedro-Núñez M, Cámara R, Paja Fano M, Ruz-Caracuel I, Fajardo C, Marazuela M, Puig-Domingo M. Araujo-Castro M, et al. Among authors: fajardo c. Endocr Relat Cancer. 2024 May 27;31(7):e240043. doi: 10.1530/ERC-24-0043. Print 2024 Jul 1. Endocr Relat Cancer. 2024. PMID: 38713182
Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain.
Lamas C, Cámara R, Fajardo C, Remon-Ruiz P, Biagetti B, Guerrero-Pérez F, Araujo-Castro M, Mora M, Hanzu F, Iglesias P, García-Centeno R, Soto A. Lamas C, et al. Among authors: fajardo c. Front Endocrinol (Lausanne). 2023 Aug 31;14:1204206. doi: 10.3389/fendo.2023.1204206. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37720528 Free PMC article.
54 results